141 related articles for article (PubMed ID: 27064244)
1. Initial hyperinsulinemia and subsequent β-cell dysfunction is associated with elevated palmitate levels.
Staaf J; Ubhayasekera SJ; Sargsyan E; Chowdhury A; Kristinsson H; Manell H; Bergquist J; Forslund A; Bergsten P
Pediatr Res; 2016 Aug; 80(2):267-74. PubMed ID: 27064244
[TBL] [Abstract][Full Text] [Related]
2. Palmitate-Induced Insulin Hypersecretion and Later Secretory Decline Associated with Changes in Protein Expression Patterns in Human Pancreatic Islets.
Groebe K; Cen J; Schvartz D; Sargsyan E; Chowdhury A; Roomp K; Schneider R; Alderborn A; Sanchez JC; Bergsten P
J Proteome Res; 2018 Nov; 17(11):3824-3836. PubMed ID: 30183308
[TBL] [Abstract][Full Text] [Related]
3. Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets.
Björklund A; Grill V
Diabetes; 1999 Jul; 48(7):1409-14. PubMed ID: 10389846
[TBL] [Abstract][Full Text] [Related]
4. Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans.
Zhou YP; Grill V
J Clin Endocrinol Metab; 1995 May; 80(5):1584-90. PubMed ID: 7745004
[TBL] [Abstract][Full Text] [Related]
5. Chronic palmitate exposure inhibits AMPKalpha and decreases glucose-stimulated insulin secretion from beta-cells: modulation by fenofibrate.
Sun Y; Ren M; Gao GQ; Gong B; Xin W; Guo H; Zhang XJ; Gao L; Zhao JJ
Acta Pharmacol Sin; 2008 Apr; 29(4):443-50. PubMed ID: 18358090
[TBL] [Abstract][Full Text] [Related]
6. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling.
Nolan CJ; Leahy JL; Delghingaro-Augusto V; Moibi J; Soni K; Peyot ML; Fortier M; Guay C; Lamontagne J; Barbeau A; Przybytkowski E; Joly E; Masiello P; Wang S; Mitchell GA; Prentki M
Diabetologia; 2006 Sep; 49(9):2120-30. PubMed ID: 16868750
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity of human islets from obese versus lean donors to chronic high glucose or palmitate.
Castex F; Leroy J; Broca C; Mezghenna K; Duranton F; Lavallard V; Lebreton F; Gross R; Wojtusciszyn A; Lajoix AD
J Diabetes; 2020 Jul; 12(7):532-541. PubMed ID: 32090456
[TBL] [Abstract][Full Text] [Related]
8. Long-term exposure to glucose and lipids inhibits glucose-induced insulin secretion downstream of granule fusion with plasma membrane.
Olofsson CS; Collins S; Bengtsson M; Eliasson L; Salehi A; Shimomura K; Tarasov A; Holm C; Ashcroft F; Rorsman P
Diabetes; 2007 Jul; 56(7):1888-97. PubMed ID: 17456851
[TBL] [Abstract][Full Text] [Related]
9. Hyperglucagonemia in youth is associated with high plasma free fatty acids, visceral adiposity, and impaired glucose tolerance.
Manell H; Kristinsson H; Kullberg J; Ubhayasekera SJK; Mörwald K; Staaf J; Cadamuro J; Zsoldos F; Göpel S; Sargsyan E; Ahlström H; Bergquist J; Weghuber D; Forslund A; Bergsten P
Pediatr Diabetes; 2019 Nov; 20(7):880-891. PubMed ID: 31271247
[TBL] [Abstract][Full Text] [Related]
10. Chronic effects of palmitate overload on nutrient-induced insulin secretion and autocrine signalling in pancreatic MIN6 beta cells.
Watson ML; Macrae K; Marley AE; Hundal HS
PLoS One; 2011; 6(10):e25975. PubMed ID: 21998735
[TBL] [Abstract][Full Text] [Related]
11. A low protein diet lowers islet insulin secretion but does not alter hyperinsulinemia in obese Zucker (fa/fa) rats.
Tse EO; Gregoire FM; Magrum LJ; Johnson PR; Stern JS
J Nutr; 1995 Jul; 125(7):1923-9. PubMed ID: 7616309
[TBL] [Abstract][Full Text] [Related]
12. Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion.
Gerst F; Wagner R; Kaiser G; Panse M; Heni M; Machann J; Bongers MN; Sartorius T; Sipos B; Fend F; Thiel C; Nadalin S; Königsrainer A; Stefan N; Fritsche A; Häring HU; Ullrich S; Siegel-Axel D
Diabetologia; 2017 Nov; 60(11):2240-2251. PubMed ID: 28791439
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and hyperinsulinemia in prepubertal obese children.
Galli-Tsinopoulou A; Karamouzis M; Nousia-Arvanitakis S
J Pediatr Endocrinol Metab; 2003; 16(4):555-60. PubMed ID: 12793608
[TBL] [Abstract][Full Text] [Related]
14. Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels.
Sabin MA; De Hora M; Holly JM; Hunt LP; Ford AL; Williams SR; Baker JS; Retallick CJ; Crowne EC; Shield JP
Pediatrics; 2007 Dec; 120(6):e1426-33. PubMed ID: 18055661
[TBL] [Abstract][Full Text] [Related]
15. Associations Between Type 2 Diabetes-Related Genetic Scores and Metabolic Traits, in Obese and Normal-Weight Youths.
Morandi A; Bonnefond A; Lobbens S; Yengo L; Miraglia Del Giudice E; Grandone A; Lévy-Marchal C; Weill J; Maffeis C; Froguel P
J Clin Endocrinol Metab; 2016 Nov; 101(11):4244-4250. PubMed ID: 27588439
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone attenuates fatty acid-induced oxidative stress and apoptosis in pancreatic beta-cells.
Saitoh Y; Chun-ping C; Noma K; Ueno H; Mizuta M; Nakazato M
Diabetes Obes Metab; 2008 Jul; 10(7):564-73. PubMed ID: 17593232
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion.
Lupi R; Del Guerra S; Marselli L; Bugliani M; Boggi U; Mosca F; Marchetti P; Del Prato S
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E560-7. PubMed ID: 14625208
[TBL] [Abstract][Full Text] [Related]
18. Identification of early biological changes in palmitate-treated isolated human islets.
Sargsyan E; Cen J; Roomp K; Schneider R; Bergsten P
BMC Genomics; 2018 Aug; 19(1):629. PubMed ID: 30134843
[TBL] [Abstract][Full Text] [Related]
19. Reversibility of metabolic and morphological changes associated with chronic exposure of pancreatic islet beta-cells to fatty acids.
Pinnick K; Neville M; Clark A; Fielding B
J Cell Biochem; 2010 Mar; 109(4):683-92. PubMed ID: 20069570
[TBL] [Abstract][Full Text] [Related]
20. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
